PL-18 / Protelight Pharma - LARVOL DELTA

First in Human Study in Healthy Volunteers of Antimicrobial Peptide PL-18 Vaginal Suppositories (clinicaltrials.gov) - P1 | N=50 | Recruiting | Sponsor: Protelight Pharmaceuticals Australia PTY LTD | Trial completion date: Feb 2023 ➔ Mar 2024 | Trial primary completion date: Aug 2022 ➔ Dec 2023

Trial completion date • Trial primary completion date • Gynecology • Vaginitis

First in Human Study in Healthy Volunteers of Antimicrobial Peptide PL-18 Vaginal Suppositories (clinicaltrials.gov) - P1 | N=50 | Recruiting | Sponsor: Protelight Pharmaceuticals Australia PTY LTD | Not yet recruiting ➔ Recruiting | Initiation date: Apr 2022 ➔ Aug 2022

Enrollment open • Trial initiation date • Gynecology • Vaginitis

First in Human Study in Healthy Volunteers of Antimicrobial Peptide PL-18 Vaginal Suppositories (clinicaltrials.gov) - P1 | N=50 | Not yet recruiting | Sponsor: Protelight Pharmaceuticals Australia PTY LTD

New P1 trial • Gynecology • Vaginitis